fbpx

IDWeek: Optimal Vancomycin Dosing using Bayesian Method Poster Presentations

IDWeek: Optimal Vancomycin Dosing using Bayesian Method Poster Presentations
2 Oct 2019 Media Release

We’re excited to share DoseMe will present two poster presentations at IDWeek 2019 in Washington, DC from October 2-6th.

Predictive Ability and Bias of Vancomycin Population PK models in an Obese Adult Population

Friday, 12:15-1:30pm EDT, Poster #1574

The aim of this study is to evaluate the performance of published vancomycin PK models in a large set of routine clinical data obtained from an obese population.

AUC24 vancomycin Bayesian-based Dosing: Increasing Therapeutic Target Attainment with Decreased TDM cost

Friday, 12:15-1:30pm EDT, Poster #1599

In this study, we compare therapeutic range attainment across five hospitals using trough-based dosing versus five hospitals using Bayesian-supported AUC24 dosing.

IDWeek

IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), and the Pediatric Infectious Diseases Society (PIDS).

The meeting is a forum for health professionals of varied backgrounds to collaborate, cooperate, and learn from each other’s expertise. It offers access to internationally recognized leaders in the field and the opportunity to network with the most highly respected health professionals in infectious diseases.

Try DoseMeRx Free Now

Learn more about our extensive range of vancomycin models plus other drug models and trial DoseMeRx free for 14-days – start your free trial now →

DoseMeRx Rated Most User-Friendly in Clinical Study -Read the study →

HIPAA Privacy Statement | Privacy policy | DoseMe & the GDPR | Copyright © 2012 - 2019 DoseMe Pty Ltd. All Rights Reserved.
DoseMe® is a registered trademark of DoseMe Pty Ltd. DoseMeRx℠ and DoseMe℞℠ are service marks of DoseMe LLC.